Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions

IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions

US Patent 10335460 · Granted Jul 2, 2019

Estimated economic value: $32,382,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells2022
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells2022
Altering the immundominance hierarchy using a DNA vaccine expressing conserved r2021
Altering the immundominance hierarchy using a DNA vaccine expressing conserved r2021
Complexes of IL-15 and IL-15Ralpha and uses thereof2021
Complexes of IL-15 and IL-15Ralpha and uses thereof2021
Complexes of IL-15 and IL-15Ralpha and uses thereof2021
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat ly2021
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat ly2021
Use of IL-15 to increase thymic output and to treat lymphopenia2021
Use of IL-15 to increase thymic output and to treat lymphopenia2021
Treatment of disease with poly-N-acetylglucosamine nanofibers2020